CHRONIC RENAL DISEASE PREDICTORS IN HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION

Cover Page

Cite item

Full Text

Abstract

Aim. To determine the predictors of decreased glomerular filtration rate (GFR) in hypertensive patients with atrial fibrillation. Materials and methods. Thirty patients with II stage hypertensive disease (HD) associated with persisting form of atrial fibrillation were examined. The program of examination included blood serum biochemical analysis with creatinine determination, GFR calculation by CKD-EPI formula, echocardiography, hemostasis indices. The results were statistically processed using the program Statistica 10,0. Results. GFR level was decreased with patient’s aging ( R = -0,49, p = 0,0006), reduced cardiac ejection fraction ( R = 0,44, p = 0,0163), left atrium size enlargement ( R = -0,66, p = 0,0001), raised von Willebrand factor activity ( R = -0,40, p = 0,0286) and accelerated thrombin formation by the external path (prothrombin time) of blood coagulation ( R = 0,54, p = 0,0023). Conclusions. Willebrand factor activity, prothrombin time, cardiac ejection fraction, left atrium size and patient’s age are predictors of chronic renal disease formation in hypertensive patients with atrial fibrillation.

About the authors

Yu I Lebedeva

Пермский государственный медицинский университет им. академика Е.А. Вагнера

Email: Julial.87@mail.ru
аспирант кафедры госпитальной терапии 614000, г. Пермь, ул. Петропавловская, д. 26

L N Nekrutenko

Пермский государственный медицинский университет им. академика Е.А. Вагнера

доктор медицинских наук, профессор кафедры госпитальной терапии 614000, г. Пермь, ул. Петропавловская, д. 26

A V Tuev

Пермский государственный медицинский университет им. академика Е.А. Вагнера

доктор медицинских наук, профессор, заведующий кафедрой госпитальной терапии 614000, г. Пермь, ул. Петропавловская, д. 26

References

  1. Кобалава Ж.Д., Виллевальде С.В., Ефремцева М.А. Основы кардиоренальной медицины. М.: ГЭОТАР-Медиа 2014; 256.
  2. Фомин В.В., Киякбаев Г.Г. Хроническая болезнь почек и фибрилляция предсердий. Клиническая нефрология 2010; 6: 34-38.
  3. Шутов А.М., Тармонова Л.Ю. Нарушение функции почек и анемия у больных пожилого возраста с диастолической сердечной недостаточностью. Терапевтический архив 2007; 79 (12): 47-51.
  4. Atar I., Kona D., Aзikel S. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006; 106 (1): 47-51.
  5. Bukowska A., Lendeckel U., Krohn A. Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney. Europace 2008; 10 (10): 1212-1217.
  6. Furberg C.D., Psaty B.M., Manolio T.A. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74 (3): 236-241.
  7. Go A.S., Hylek E.M., Phillips K.A. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285 (18): 2370-2375.
  8. Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., Grobbee D.E., Jaarsma T., Kirchhof P., Kjeldsen S.E., Laurent S., Manolis A.J., Nilsson P.M., Ruilope L.M. ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34 (28): 2159-2219.
  9. Soliman E.Z., Prineas R.J., Go A.S. Chronic renal insufficiency cohort (CRIC) Study Group. Chronic kidney disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC). Am Heart J 2010; 159 (6): 1102-1107.
  10. Watanabe H., Watanabe T., Sasaki S. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009; 158 (4): 629-636.

Copyright (c) 2017 Lebedeva Y.I., Nekrutenko L.N., Tuev A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies